Plasma amyloid β and risk of Alzheimer’s disease in the Framingham Heart Study

BACKGROUND: Plasma amyloid β (Aβ) peptides levels have been examined as a low-cost, accessible marker for risk of incident Alzheimer’s disease (AD) and dementia, but results have varied between studies. We reassessed these associations in one of the largest, prospective, community-based studies to d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Alzheimers Dement
Main Authors: Chouraki, Vincent, Beiser, Alexa, Younkin, Linda, Preis, Sarah Rosner, Weinstein, Galit, Hansson, Oskar, Skoog, Ingmar, Lambert, Jean-Charles, Au, Rhoda, Launer, Lenore, Wolf, Philip A, Younkin, Steven, Seshadri, Sudha
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362883/
https://ncbi.nlm.nih.gov/pubmed/25217292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.07.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki